HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Satoaki Matoba Selected Research

Collagen Diseases (Collagen Disease)

3/2020Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-derived Mononuclear Cell Implantation in Patients with No-option Critical Limb Ischemia.
1/2019Impact of Therapeutic Angiogenesis Using Autologous Bone Marrow-Derived Mononuclear Cells Implantation in Critical Limb Ischemia With Scleroderma - Subanalysis of the Long-Term Clinical Outcomes Survey.
1/2018Long-Term Clinical Outcomes Survey of Bone Marrow-Derived Cell Therapy in Critical Limb Ischemia in Japan.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Satoaki Matoba Research Topics

Disease

25Myocardial Infarction
01/2022 - 06/2003
15Heart Failure
01/2022 - 07/2004
14Atherosclerosis
01/2021 - 03/2005
12Infarction (Infarctions)
01/2022 - 06/2003
11Chronic Limb-Threatening Ischemia
02/2022 - 02/2008
8Ischemia
04/2022 - 06/2003
7Fibrosis (Cirrhosis)
01/2022 - 11/2009
7Cardiomyopathies (Cardiomyopathy)
11/2021 - 01/2009
6Aortic Valve Stenosis (Aortic Stenosis)
10/2022 - 01/2020
6Neoplasms (Cancer)
01/2022 - 06/2006
6Hypoxia (Hypoxemia)
01/2022 - 08/2003
5Chronic Renal Insufficiency
01/2022 - 08/2012
5Hypertrophy
01/2022 - 11/2009
5Insulin Resistance
01/2020 - 01/2013
4Reperfusion Injury
01/2022 - 09/2003
4Inflammation (Inflammations)
01/2022 - 05/2006
4Hypertension (High Blood Pressure)
01/2022 - 01/2018
4Thrombosis (Thrombus)
01/2021 - 01/2015
4Pathologic Constriction (Stenosis)
11/2020 - 07/2006
4Thromboangiitis Obliterans (Buerger's Disease)
09/2020 - 11/2008
4Atherosclerotic Plaque (Atheroma)
02/2015 - 05/2006
3Pulmonary Hypertension
01/2022 - 04/2015
3Obesity
01/2022 - 01/2013
3Collagen Diseases (Collagen Disease)
03/2020 - 01/2018
3Arteriosclerosis Obliterans
03/2020 - 01/2018
3Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 08/2009
3Peripheral Arterial Disease
03/2017 - 11/2008
3Necrosis
08/2003 - 05/2002
2Wounds and Injuries (Trauma)
02/2022 - 03/2020
2Sepsis (Septicemia)
01/2022 - 11/2012
2ST Elevation Myocardial Infarction
01/2022 - 10/2017
2Stroke (Strokes)
01/2022 - 07/2019
2Cardiogenic Shock
01/2022 - 01/2014
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 02/2014
2Pulmonary Arterial Hypertension
01/2022 - 01/2016
2Infections
01/2022 - 01/2021
2Aneurysm (Aneurysms)
12/2021 - 10/2019
2Immunoglobulin G4-Related Disease
12/2021 - 08/2019
2Venous Thrombosis (Deep-Vein Thrombosis)
01/2021 - 11/2019
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2021 - 01/2021
2Embolism (Embolus)
12/2020 - 07/2019
2Myocardial Ischemia (Ischemic Heart Diseases)
12/2020 - 04/2010
2Acute Coronary Syndrome
11/2020 - 04/2010
2Hemorrhage
04/2019 - 06/2011
2Cardiomegaly (Heart Hypertrophy)
01/2019 - 01/2016
2Proteinuria
01/2019 - 01/2014
2Ulcer
05/2018 - 11/2008
2Diabetes Mellitus
05/2018 - 01/2015
2Diabetic Nephropathies (Diabetic Nephropathy)
01/2018 - 01/2018
2Body Weight (Weight, Body)
01/2018 - 01/2015
2Diabetic Cardiomyopathies
02/2017 - 01/2012
2Glucose Intolerance
01/2015 - 02/2014

Drug/Important Bio-Agent (IBA)

10Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2003
8Glucose (Dextrose)FDA LinkGeneric
01/2022 - 08/2003
8Apolipoproteins E (ApoE)IBA
01/2021 - 09/2013
4CytokinesIBA
01/2022 - 05/2002
4Cisplatin (Platino)FDA LinkGeneric
10/2021 - 01/2017
4LipidsIBA
11/2020 - 10/2010
4Troleandomycin (TAO)FDA Link
09/2020 - 11/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
01/2020 - 03/2003
4Doxorubicin (Adriamycin)FDA LinkGeneric
01/2014 - 03/2003
4Creatine Kinase (Creatine Phosphokinase)IBA
01/2014 - 07/2011
3Pharmaceutical PreparationsIBA
01/2022 - 03/2017
3Caspase 3 (Caspase-3)IBA
01/2019 - 08/2003
3Adenosine Triphosphate (ATP)IBA
01/2012 - 05/2002
2Streptozocin (Streptozotocin)FDA Link
01/2022 - 02/2014
2LipopolysaccharidesIBA
01/2022 - 11/2012
2SodiumIBA
01/2022 - 01/2018
2DNA (Deoxyribonucleic Acid)IBA
01/2022 - 08/2003
2EnzymesIBA
12/2021 - 01/2018
2Prealbumin (Transthyretin)IBA
11/2021 - 01/2009
2CreatinineIBA
05/2021 - 11/2019
23-Iodobenzylguanidine (Iobenguane)IBA
01/2021 - 01/2020
2AnticoagulantsIBA
11/2020 - 11/2019
2Thallium-201IBA
01/2020 - 09/2018
2Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA
12/2018 - 05/2009
2Oxygen (Dioxygen)IBA
01/2018 - 11/2008
2Angiotensin Receptor AntagonistsIBA
01/2018 - 03/2015
2Fatty Acids (Saturated Fatty Acids)IBA
12/2017 - 02/2017
2Caveolin 3IBA
01/2016 - 12/2015
2Messenger RNA (mRNA)IBA
01/2016 - 07/2006
2Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
04/2015 - 05/2011
2Insulin (Novolin)FDA Link
09/2013 - 01/2013
2Electron Transport Complex IV (Cytochrome c Oxidase)IBA
01/2012 - 06/2006
2Nitric Oxide Synthase (NO Synthase)IBA
08/2007 - 09/2003

Therapy/Procedure

20Percutaneous Coronary Intervention
01/2022 - 08/2007
19Therapeutics
04/2022 - 07/2006
8Transcatheter Aortic Valve Replacement
10/2022 - 10/2019
7Stents
12/2021 - 08/2007
7Transplantation
01/2018 - 08/2007
4Surgical Amputation (Amputations)
02/2022 - 11/2008
4Cell- and Tissue-Based Therapy (Cell Therapy)
01/2018 - 08/2007
3Catheters
01/2022 - 08/2019
3Intra-Aortic Balloon Pumping
01/2022 - 08/2007
3Cell Transplantation
01/2018 - 11/2008
3Carotid Endarterectomy
07/2006 - 03/2005
2Conservative Treatment
01/2022 - 01/2020
2Drug Therapy (Chemotherapy)
01/2021 - 01/2017
2Punctures
04/2019 - 11/2012
2Intramuscular Injections
12/2018 - 11/2008